HIRSCHMAN ORIN 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-20 08:08 am Sale |
2023-03-16 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 2,802,115 4.900% |
-1,354,776 (-32.59%) |
Filing |
| 2023-02-15 07:18 am Purchase |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 4,156,891 7.500% |
269,719 (+6.94%) |
Filing |
| 2022-07-07 2:58 pm Purchase |
2022-07-05 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 3,887,172 7.700% |
1,067,105 (+37.84%) |
Filing |
| 2022-03-09 08:10 am Purchase |
2022-02-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 2,820,067 5.600% |
2,820,067 (New Position) |
Filing |